A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1997
11/20/1997	WO1997042980A1 Methods of terminal sterilization of biological products
11/20/1997	WO1997042971A1 Recombinant neospora antigens and their uses
11/20/1997	WO1997042970A1 Depigmentating agent in the treatment of melasma
11/20/1997	WO1997042969A1 USE OF IL-12 AND IFN-α FOR THE TREATMENT OF INFECTIOUS DISEASES
11/20/1997	WO1997042968A2 Administration of histamine for therapeutic purposes
11/20/1997	WO1997042967A1 Antithrombotic materials and methods
11/20/1997	WO1997042966A1 Therapeutic uses of bpi protein products for human meningococcemia
11/20/1997	WO1997042965A1 Amelioration of erectile dysfunction
11/20/1997	WO1997042947A1 Methods of treating type i hypersensitivity using monophosphoryl lipid a
11/20/1997	WO1997042940A1 Method for fabricating polymer-based controlled-release devices
11/20/1997	WO1997042900A1 Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
11/20/1997	WO1997042825A1 Antimicrobial peroxidase compositions
11/20/1997	WO1997042820A1 Tristetraprolin
11/20/1997	WO1997038664A3 A method of treating cancer
11/20/1997	WO1997035994A3 Cytochrome p450 transducing retroviral vectors
11/20/1997	DE3645343C2 Low dosage interferon administration to warm blooded vertebrates
11/20/1997	DE19720437A1 Oral composition for plaque suppression and removal
11/20/1997	CA2266408A1 A basal cell carcinoma tumor suppressor gene
11/20/1997	CA2255669A1 Collagen binding protein compositions and methods of use
11/20/1997	CA2255026A1 Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
11/20/1997	CA2254783A1 Cortistatin: neuropeptides, compositions and methods
11/20/1997	CA2254343A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
11/20/1997	CA2254122A1 Synthetic inhibitors of hepatitis c virus ns3 protease
11/20/1997	CA2253942A1 Common gamma chain blocking agents
11/20/1997	CA2253851A1 Tsetse thrombin inhibitor
11/20/1997	CA2253836A1 Antithrombotic materials and methods
11/20/1997	CA2253667A1 Method for fabricating polymer-based controlled-release devices
11/20/1997	CA2253365A1 Administration of histamine for therapeutic purposes
11/20/1997	CA2251547A1 Recombinant neospora antigens and their uses
11/20/1997	CA2247392A1 Vehicle for the transport of molecular substances
11/19/1997	EP0807687A2 Herpesviral proteases, compositions capable of binding them and uses thereof.
11/19/1997	EP0807686A2 Interleukin-1 beta converting enzyme like apoptotic protease-7
11/19/1997	EP0807684A1 Human G-protein coupled receptor (HIBCD07)
11/19/1997	EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/19/1997	EP0807639A2 Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity
11/19/1997	EP0807638A1 Inhibitors and substrates of thrombin
11/19/1997	EP0807624A2 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
11/19/1997	EP0807439A2 Method of treating sepsis and adult respiratory distress syndrome
11/19/1997	EP0807185A1 Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
11/19/1997	EP0807183A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
11/19/1997	EP0807181A1 NOVEL c-MPL LIGANDS
11/19/1997	EP0807178A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
11/19/1997	EP0807175A2 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY
11/19/1997	EP0807174A1 Modified ligands for receptor tyrosine kinases
11/19/1997	EP0807172A1 Human immunodeficiency virus transcription inhibitors and methods of their use
11/19/1997	EP0807165A1 RECOMBINANT $g(a)-GALACTOSIDASE ENZYME
11/19/1997	EP0807125A2 Monoclonal antibodies anti-cd6 and their uses
11/19/1997	EP0807124A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
11/19/1997	EP0807123A1 Granulocyte colony-stimulating factor receptor (g-csf-r) interactive molecules
11/19/1997	EP0807122A1 Novel receptor
11/19/1997	EP0807121A1 New pharmaceuticals for modulating hormone responsiveness
11/19/1997	EP0806967A1 Gene transfer for treating a connective tissue of a mammalian host
11/19/1997	EP0806965A1 Cd44 expression in smooth muscle cells
11/19/1997	EP0806963A1 Carcinoma treatment
11/19/1997	EP0806962A1 Methods for the treatment of acid aspiration-induced acute lung injury
11/19/1997	EP0806961A1 Anti-obesity proteins
11/19/1997	EP0806960A1 Extracts of shark cartilage, process of production and uses thereof
11/19/1997	EP0806958A1 Inhibition of platelet binding
11/19/1997	EP0806945A1 Therapeutic preparation for inhalation containing parathyro d hormone, pth
11/19/1997	EP0754188B1 Oligonucleotides with anti-cytomegalovirus activity
11/19/1997	EP0731807A4 N-2 substituted purines
11/19/1997	EP0719279B1 Process for purifying 1- n(2 -((s)-ethoxycarbonyl)-3-phenylpropyl)-n6 -trifluoroacetyl]-l-lysyl-l-prolin (lisinopril(tfa)ethylester)
11/19/1997	EP0705107A4 Interleukin-2 stimulated t lymphocyte cell death for the treatment of autoimmune diseases, allergic disorders, and graft rejection
11/19/1997	EP0557300B1 Bispecific antibodies, method of production, and uses thereof
11/19/1997	EP0536177B1 Thrombin inhibitors based on the amino acid sequence of hirudin
11/19/1997	EP0502146B1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEIN gE
11/19/1997	EP0341252B1 Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis
11/19/1997	CN1165537A Novel PKA-binding proteins and uses thereof
11/19/1997	CN1165521A Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
11/19/1997	CN1165479A Sustained release of peptides from pharmaceutical compositions
11/19/1997	CN1165477A Delivery of solid drug compositions
11/19/1997	CN1165147A Guanine nudeotide combined protein coupled receptor proteins, their production and use
11/19/1997	CN1165146A Process for purifying Tamm-Horsfall glycoprotein or uromodulin, their purified products and method for making discrimination between both of them
11/19/1997	CN1165034A Pharmaceutical preparation containing human growth hormone
11/19/1997	CN1165033A Isolation of novel peptides from green barley leaf extract and use of same to inhibit human platelet aggregation
11/18/1997	US5689048 Biocidal proteins
11/18/1997	US5688992 Compounds for treatment of signaling pathways in immune disfunction, cancer and diabetes
11/18/1997	US5688946 Amino acid derivatives having renin inhibiting activity
11/18/1997	US5688938 Calcium receptor-active molecules
11/18/1997	US5688936 Vesicle membrane transport proteins
11/18/1997	US5688935 Cells and clots
11/18/1997	US5688927 Hybridoma cells producing monoclonal antibodies
11/18/1997	US5688918 Antitumor
11/18/1997	US5688913 CS-1 peptidomimetics, compositions and methods of using the same
11/18/1997	US5688824 Use of leflunomide to prevent or control xenograft rejection
11/18/1997	US5688794 Administering metoclopramide
11/18/1997	US5688783 Salinamides
11/18/1997	US5688773 Method of selectively destroying neoplastic cells
11/18/1997	US5688771 Lipophilic oligopeptides with immunomodulating activity
11/18/1997	US5688770 Antiglaucoma compositions and methods
11/18/1997	US5688769 Oligopeptide for inhibiting ovarian steroidogenesis
11/18/1997	US5688768 Recombinant thrombin receptor and related pharmaceuticals
11/18/1997	US5688767 Treatment of endotoxin-associated disorders with cationic peptides
11/18/1997	US5688766 Cystatin proteins
11/18/1997	US5688765 Dry eyes
11/18/1997	US5688763 Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
11/18/1997	US5688762 Method of treating hypertension using animal stomach mucosa extract and endogenous protease-inhibitor peptides
11/18/1997	US5688761 Convertible microemulsion formulations
11/18/1997	US5688760 Polypeptides having bone resorption inhibitory activity comprising PTHrP-derived sequences
11/18/1997	US5688690 Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto

1 ... 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 ... 3163